Picton Mahoney Asset Management Adma Biologics, Inc. Transaction History
Picton Mahoney Asset Management
- $9.71 Billion
- Q2 2025
A detailed history of Picton Mahoney Asset Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 437,717 shares of ADMA stock, worth $6.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
437,717
Previous 132,568
230.18%
Holding current value
$6.5 Million
Previous $2.63 Million
203.12%
% of portfolio
0.08%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
391Shares Held
190MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21MShares$311 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$277 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$190 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$179 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$87.8 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.91B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...